Baltic Conference of Hematology 2025 - Sobi

Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases.

• Ensuring every eligible person living with a rare and debilitating disease within our disease areas is given the opportunity to benefit from our approved medicines
• Delivering innovative solutions from our pipeline
• Maintaining our commitment to patients, our employees, and society.

Contact person in Tallinn: Raimonds Simanis, e-mail: [email protected]

www.sobi.com/en